CAS number: 55-98-1

General information about the Busulfan active pharmaceutical ingredient

Busulfan as active pharmaceutical ingredient (API) is an alkylating agent used to treat chronic leukemia. Busulfan is a medication used for chronic myelogenous leukemia and also used as a component in patients undergoing bone marrow transplantation. Busulfan comes as oral tablets, injectable solution.

Axplora manufactures Busulfan API

Busulfan API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Busulfan API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Busulfan API is commercially available as standard grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Busulfan API.
  • Therapeutic area Anti-Cancer
  • Monograph PH.EUR.
  • Available grade Standard
  • Regulatory documentation US DMF#
  • Produced in GRO